News

  • Insilico signs US$888m oncology deal with Servier

    Insilico has signed a multi-year US$888m oncology deal with Servier to use AI in discovering and developing cancer therapies. The AI-driven drug discovery company will use its Pharma.AI platform to identify and advance potential drug candidates, while Servier will lead clinical validation, regulatory interactions and worldwide commercialisation. Under the agreement, Insilico will be eligible to [...]

  • UK bans junk food ads before 9pm to protect child health

    The UK has banned junk food adverts on TV before 9pm and online at all times to tackle childhood obesity. The rules are expected to remove up to 7.2bn calories from children's diets each year, reduce the number of children living with obesity by 20,000 and deliver around £2bn in health benefits over time. Evidence [...]

  • Concurrent frailty and depression likely boost dementia risk in older people, study finds

    Concurrent physical frailty and depression likely boost the risk of dementia in older people, with the interaction of these two factors alone contributing around 17 per cent of the overall risk, suggest the findings of a large international study. Globally, some 57 million people are living with dementia - a figure that is expected to [...]

  • Loss of confidence in midlife linked to dementia

    A decline in personal confidence or concentration during midlife could signal an elevated risk of developing dementia later in life, new research suggests. Researchers identified six specific symptoms in middle age that may serve as early markers of underlying neurodegenerative processes, meaning gradual damage to brain cells. The findings stem from an analysis of data [...]

  • Sanofi and ADEL sign US$1.04bn Alzheimer’s deal

    South Korea’s ADEL has signed a US$1.04bn Alzheimer’s partnership with Sanofi to develop and sell an experimental antibody now in early US trials. Under the agreement, ADEL receives an upfront US$80m, plus milestones tied to development and commercial progress, and royalties on future sales. Sanofi also signed a separate deal with private biotech Dren Bio [...]

  • Mindoo raises €5m for hospital AI automation

    Antwerp's Mindoo has raised €5m seed funding to expand its hospital AI agents that handle routine tasks and ease workload. Mindoo builds "agentic" workflows, meaning software agents that follow set rules to complete tasks such as intake, documentation and follow-up, with controls for safety and oversight. The platform offers four configurable agents for reception, pre-visit [...]

  • Yellow wristbands launched to help locate people with dementia

    Durham Constabulary has launched bright yellow wristbands to help locate people with dementia who go missing. The force is one of many police forces across the country rolling out the initiative, which aims to reduce harm and find people quickly with minimal adverse outcomes. The wristbands, rolled out this month, contain the person’s name and [...]

  • Vaccine raises hope for million living with knee osteoarthritis

    A knee osteoarthritis vaccine shows promising results in patients, offering hope to millions in the UK with the condition. The degenerative condition occurs when protective joint cartilage wears down, causing pain, stiffness and swelling. It affects about 10 million people in the UK, has no cure, and is managed with physiotherapy, exercise and weight loss. [...]

  • Commonly-prescribed drugs liked to 50% increased risk of dementia

    Commonly used anticholinergic drugs may raise dementia risk by about 50 per cent, research into medicines for bladder problems and depression suggests. Regular daily use of strong anticholinergic medicines for three years or more was linked to a markedly higher dementia risk in older adults. Anticholinergic drugs block acetylcholine, a chemical messenger in the nervous [...]

  • £2m backs speech AI for early dementia care

    Punto Health has raised £2m seed funding to develop its speech-based AI platform for early dementia detection and personalised care. The platform analyses short voice recordings for patterns linked to memory, attention and language change. Those patterns form a digital biomarker, a measurable signal captured by a device. Punto Health’s multilingual suite includes PuntoTest, a [...]